The Business Times
The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

Gates Foundation to invest up to US$40m in UK immunotherapy firm Immunocore

Published Mon, Sep 18, 2017 · 07:02 AM
Share this article.

[LONDON] The Bill & Melinda Gates Foundation is to invest up to US$40 million in privately held British biotech company Immunocore to support its development of immunotherapies for infectious diseases.

Oxford-based Immunocore has so far concentrated on developing its T-cell receptor medicines to fight cancer, where it has collaborations with Roche, GlaxoSmithKline, AstraZeneca and Eli Lilly.

The tie-up with the Gates Foundation will extend the work into finding and developing new treatments for tuberculosis, HIV and other infectious diseases.

REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here